baber/WOPTO huggingface dataset:
Patent AT-E209512-T1 (AT)
Inventor: SWEEZER WILLIAM P
IPC: A61M25/00
Filed: 1995-05-26
Granted: 2001-12-15
Abstract: A catheter system and devices for achieving total cardiopulmonary bypass during heart surgery are provided. The venous perfusion catheter has first and second balloons occluding the inferior and superior vena cava thereby precluding blood flow into the right atrium. An arterial perfusion catheter is inserted, advanced and positioned in the ascending aorta cephalid of the junction of the coronary arteries with the aortic root. A second flexible arterial cannula is mounted in sliding relationship with the first flexible cannula and carries an inflatable balloon adjacent its distal end to provide for occlusion of the ascending aorta. A first flexible cannula has a first lumen and an arterial venting orifice communicating with the first lumen defining a single flow path for the passage of cardioplegia solution to arrest the heart or for the evacuation of blood from the aortic root. A third lumen extends axially through the first flexible arterial cannula and communicates with a multiplicity of openings in the distal tip for suctioning blood from the left ventricle. The second flexible cannula of the arterial perfusion catheter has a first cavity extending axially therethrough that communicates with an opening at its distal tip to permit the passage of blood delivered by the cardiopulmonary bypass pump into arterial circulation. Both the venous and arterial perfusion catheters have a plurality of radially and oppositely spaced steering lumens and a plurality of steering cables fixed to the distal ends to achieve omnidirectional articulation. <IMAGE>
Patent AT-E206044-T1 (AT)
Inventor: BERGSTRAND PONTUS JOHN ARVID
IPC: A61K9/28
Filed: 1995-06-07
Granted: 2001-10-15
Abstract: An oral pharmaceutical multiple unit tabletted dosage form comprises tablet excipients and individually enteric-coated layered units of a core material contg. omeprazole (5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl) sulphinyl)-1H-benzimidazole) or 1 of its alkaline salts, or a single enantiomer, opt. mixed with alkaline cpds., covered with 1 or more layers, at least 1 being an enteric coating layer. The mechanical properties of the enteric coating layer ensure that acid resistance of the individual coated units is not significantly affected when they are compressed with excipients into tablets.
Patent AT-E244004-T1 (AT)
Inventor: MOECKEL JOERN
IPC: A61K9/48
Filed: 1995-09-14
Granted: 2003-07-15
Abstract: PCT No. PCT/EP95/03610 Sec. 371 Date Mar. 14, 1997 Sec. 102(e) Date Mar. 14, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/08243 PCT Pub. Date Mar. 21, 1996The present invention concerns pharmaceutical compositions containing metformin as an active substance and a hydrocolloid-forming agent as a retardant and optionally standard pharmaceutical auxiliary substances, the residual moisture content in the pharmaceutical composition being 0.5-3% by weight. The invention also concerns a process for producing pharmaceutical compositions containing metformin as an active substance and a hydrocolloid-forming agent as a retardant and optionally standard pharmaceutical auxiliary substances characterized in that the active substance and retarding agent or a portion thereof are granulated with an aqueous solvent which can optionally contain a binder and where appropriate the other portion of the retardant or other standard pharmaceutical auxiliaries are admixed with the granulate which is then dried until the residual moisture content is reduced to 0.5-3% by weight.
Patent AT-E178727-T1 (AT)
Inventor: HOGGE JOHN C
IPC: G05B19/418
Filed: 1995-09-18
Granted: 1999-04-15
Abstract: A planning coordination system (30) and method are provided that automatically coordinate a planning system (32) associated with a first factory (28) with separate planning systems (16, 24, 40) of a plurality of factories (12, 20, 36) in a manufacturing chain. The planning coordination system (30) communicates with the planning system (32) of the first factory (28) and communicates with separate planning coordination systems (14, 38) of the other factories (12, 36) with which the first factory (28) has demand and supply part relationships. The planning coordination system (30) receives and processes demands and responses communicated by the planning coordination systems (14, 38) of the other factories (12, 36). The planning coordination system (30) provides planning information to the planning system (32) of the first factory (28) and obtains information about products to be produced and parts needed from an output plan (34) of that planning system (32). The planning coordination system (30) communicates responses to the planning coordination system (14) of each factory (12) from which a demand was received in order to provide supply part information and communicates a demand to the planning coordination system (38) of each factory (36) from which parts are needed in order to provide demand part information. The planning coordination system (30) repeats receiving, processing, providing, obtaining and communicating such that the planning system (32) of the first factory (30) can adjust the output plan (34) responsive to the demands and responses communicated between the first factory (28) and the other factories (12, 36).
Patent AT-E320004-T1 (AT)
Inventor: NACAMULLI LAURETTE
IPC: G01N33/532
Filed: 1995-12-04
Granted: 2006-03-15
Abstract: The rate of a biomolecular reaction, such as an enzymatic reaction or an affinity binding reaction, is measured using electrochemiluminescence ("ECL"). The reaction is conducted in an electrochemical cell with a mixture of reagents including a luminophore which will relate the concentration of a reactant, a reaction partner or the reaction product of a reaction partner to the ECL intensity. The reaction partner is a reagent which reacts with the reactant and which participates with the luminophore (or its reaction product participates with the luminophore) to cause the emission of ECL. The ECL intensity is modulated with a series of electrical pulses which are applied to the mixture of reagents at a preselected potential and for preselected intervals of time and duration. The ECL intensity is measured at the same intervals to provide a timed series of values (P). The same experiment is repeated except that the modulation is conducted after the reaction has gone to completion to obtain a timed series of values (C). The same experiment is repeated a third time in the absence of the reaction partner to obtain a times series of values (B). The results are normalized (N) using the following formula: <maths id="MATH-US-00001" num="1"> <MATH OVERFLOW="SCROLL"> <MTABLE> <MTR> <MTD> <MROW> <MI>N</MI> <MO>=</MO> <MFRAC> <MROW> <MI>P</MI> <MO>-</MO> <MI>B</MI> </MROW> <MROW> <MI>C</MI> <MO>-</MO> <MI>B</MI> </MROW> </MFRAC> </MROW> </MTD> <MTD> <MROW> <MO>(</MO> <MI>I</MI> <MO>)</MO> </MROW> </MTD> </MTR> </MTABLE> </MATH> </MATHS> to obtain a series of values N which can be used to plot the time course (concentration vs. time) of the reaction.
Patent AT-E191740-T1 (AT)
Inventor: VON BONIN WULF DR
IPC: E06B5/16
Filed: 1996-01-10
Granted: 2000-04-15
Abstract: Gel formers comprising acid aluminum phosphate and a reaction product of boric acid and an alkanolamine, and further comprising alkali metal compounds in the aluminum: alkali metal ratio of 1:1.3-2.5 require short gelling times, and form gels having improved melting resistance.
Patent AT-E200842-T1 (AT)
Inventor: RUPP ARNULF
IPC: H05B41/298
Filed: 1996-02-08
Granted: 2001-05-15
Abstract: The gas-discharge tube (LP) with e.g. its preheater (VH) is connected to the output of a generator (G) of AC at a predetermined high frequency from the mains supply. A control input of the generator is connected to a switch-off device (AV) producing a signal (CS1) when activated by the detector (VE) of the peak-to-peak voltage across the lamp. The output (UA) of the detector is proportional to the detected peak-to-peak voltage. When this output exceeds a threshold value the generator is switched off.
Patent AT-E214005-T1 (AT)
Inventor: CERRI LUCIANO
IPC: B42F13/00
Filed: 1996-06-03
Granted: 2002-03-15
Abstract: The device for retaining sheets, files, or punched cards in binders has a body (1) defining a base portion (2) that can be associated with the cover (3) of a binder (4). Two arms (5,6) extend from the base portion (2) and constitute the two arms of an open ring. The two arms (5,6) can move towards each other at their free ends, (5a,6a) which lie opposite to the base portion (2). The free ends (5a,6a) are provided respectively with a tooth (7) and a seat (8), for mutual engagement. The tooth (7) can be engaged with or released from the seat (8) to close or open the ring. <IMAGE>
Patent AT-E167333-T1 (AT)
Inventor: ZIEGLER HORST
IPC: H01Q1/22
Filed: 1996-11-08
Granted: 1998-06-15
Abstract: The heat consumption measuring equipment involved uses a radio means for measuring the figure recorded by a counter, and a temperature sensor (10) thermally connected to the heat consumer or heating body. This sensor is connected through an A/D converter (12) with a digital multiplier (14), receiving the output signal of a ROM (16) with its characteristic values, and sending its results to the integrating circuit (22). The figures summed are display on the indicating panel (24). The results are sent also to a modulator (32) and its output is sent to the UHF transmitting circuit (34) for passing to the antenna unit (36). This unit includes a feed inductance (40) with a condenser (42), and this resonance circuit connects the two terminals, transmitting to a central station.
Patent AT-E179705-T1 (AT)
Inventor: CROCCO GUY L
IPC: B01J25/02
Filed: 1996-03-11
Granted: 1999-05-15
Abstract: Epoxides are produced by an integrated process involving molecular oxygen oxidation of a secondary alcohol, separation of the ketone co-product, and epoxidation of an olefin using the ketone-free oxidation product in the presence of a titanium silicalite catalyst and a methanol-containing diluent wherein methanol recovered from the epoxidation product mixture serves as a source of methanol in the epoxidation step.
Patent AT-E173406-T1 (AT)
Inventor: BUECHERL SEBASTIAN
IPC: F04B9/02
Filed: 1996-02-09
Granted: 1998-12-15
Abstract: PCT No. PCT/DE96/00236 Sec. 371 Date Sep. 25, 1997 Sec. 102(e) Date Sep. 25, 1997 PCT Filed Feb. 9, 1996 PCT Pub. No. WO96/24394 PCT Pub. Date Aug. 15, 1996The invention concerns an artificial heart driving device having at least one blood chamber which is disposed in a pump housing and draws in and expels blood cyclically by means of a plurality of pressure plates which can be driven by a motor. The motor is directly connected to a drive gear or cam component. A movement component actuating the plurality of pressure plates engages with the drive gear or cam component and performs a reciprocating movement as the drive gear or cam component rotates.
Patent AT-E312600-T1 (AT)
Inventor: JOHNSON KEITH A
IPC: A61K31/70
Filed: 1996-05-30
Granted: 2005-12-15
Abstract: The invention provides an agglomerate composition composed of units of aggregated fine particles and methods for its manufacture and use. The agglomerate composition units are composed of fine particles having a mean particle size in the range of 1  mu m to 5  mu m, and usually includes a medicament powder. The agglomerate units have a mean size in the range from 200  mu m to 500  mu m and have a friability index in the range from about 10 to 60.
Patent AT-E197737-T1 (AT)
Inventor: KING PAUL
IPC: G01N33/497
Filed: 1996-06-14
Granted: 2000-12-15
Abstract: PCT No. PCT/GB96/01419 Sec. 371 Date Dec. 17, 1997 Sec. 102(e) Date Dec. 17, 1997 PCT Filed Jun. 14, 1996 PCT Pub. No. WO97/00443 PCT Pub. Date Jan. 3, 1997This invention consists of breath testing apparatus 10 comprising a breath tube 11, a fuel cell housing 12 incorporating a pump system 12a, a fuel cell 13, a control and computational unit 14, and a display 15. A thermistor 22 is provided to detect the temperature of the housing 12 during measurement and the unit 14 compensates the fuel cell output in accordance with the detected temperature.
Patent AT-E183488-T1 (AT)
Inventor: KAHL WALTHER
IPC: C04B41/52
Filed: 1996-06-20
Granted: 1999-09-15
Abstract: A concrete moulding with a shining surface is treated with an alkaline silicate solution in order to increase the shining effect and to better bind the shining pigment into a concrete matrix.
Patent AT-E286277-T1 (AT)
Inventor: TRIAL FRANCOIS
IPC: G06K7/08
Filed: 1996-08-12
Granted: 2005-01-15
Abstract: Device for reading cheques, particularly the track comprising the account identification number, and comprising two stacked generally parallelepiped-shaped parts (1, 2) made from an insulating material and joined to each other so as to leave an intermediate longitudinal slot having a width that only allows one cheque (8) to be inserted therein. The upper part (1) has a first read head (4) for reading the cheques (8), and a second read head (4') for detecting surrounding electromagnetic interference and for correcting the signal from the first read head (4) so that the indiciae to be read on the cheque are restored without error. The signals from both heads (4, 4') are processed by an electronic card (7) located in a housing (6) in the upper part (1), two magnets (5, 5') being located on either side of the first read head (4).
Patent AT-E236396-T1 (AT)
Inventor: AMRANI MOHAMMED EL HASSAN
IPC: G01N27/12
Filed: 1996-11-18
Granted: 2003-04-15
Abstract: There is disclosed a method for interrogating a sensor comprising the steps: applying a periodic electrical signal to the sensor; obtaining a signal therefrom; and performing an operation on the obtained signal to obtain the sensor response at a plurality of frequencies, said operation including a transformation to the frequency domain of said signal or a quantity related to said signal.
Patent AT-E199572-T1 (AT)
Inventor: LIZARDI PAUL M
IPC: C12N15/09
Filed: 1996-11-21
Granted: 2001-03-15
Abstract: Disclosed are compositions and a method for amplification of and multiplex detection of molecules of interest involving rolling circle replication. The method is useful for simultaneously detecting multiple specific nucleic acids in a sample with high specificity and sensitivity. The method also has an inherently low level of background signal. A preferred form of the method consists of an association operation, an amplification operation, and a detection operation. The association operation involves association of one or more specially designed probe molecules, either wholly or partly nucleic acid, to target molecules of interest. This operation associates the probe molecules to a target molecules present in a sample. The amplification operation is rolling circle replication of circular nucleic acid molecules, termed amplification target circles, that are either a part of, or hybridized to, the probe molecules. A single round of amplification using rolling circle replication results in a large amplification of the amplification target circles. Following rolling circle replication, the amplified sequences are detected using combinatorial multicolor coding probes that allow separate, simultaneous, and quantitative detection of multiple different amplified target circles representing multiple different target molecules. Since the amplified product is directly proportional to the amount of target sequence present in a sample, quantitative measurements reliably represent the amount of a target sequence in a sample. Major advantages of this method are that a large number of distinct target molecules can be detected simultaneously, and that differences in the amounts of the various target molecules in a sample can be accurately quantified. It is also advantageous that the DNA replication step is isothermal, and that signals are strictly quantitative because the amplification reaction is linear and is catalyzed by a highly processive enzyme.
Patent AT-E321880-T1 (AT)
Inventor: MONTMINY MARC R
IPC: C12N15/09
Filed: 1996-11-27
Granted: 2006-04-15
Abstract: The present invention provides a method to design compounds that mimic the effects of Pbx in stabilizing STF-1 binding. Using well known DNA binding assays, a person having ordinary skill in this art would be able to screen compounds to determine drugs effective in promoting STF-1 binding to DNA. In this way, one will be able to discover new compounds useful in stimulating somatostatin and insulin production.
Patent AT-E215329-T1 (AT)
Inventor: GROSCH KARL
IPC: A47B9/14
Filed: 1997-05-16
Granted: 2002-04-15
Abstract: The longitudinal frame members are fastened at their ends to two lateral frame members. These members are fastened at their ends to metal tubes which make up the legs of the table. The individual frame members (11) are made of extruded profiles of light alloy. They are of rectangular section. The long walls are of thin plain section, while the short walls are thickened with inward-facing projections (12) which define part-circular grooves (13). These are adapted to accommodate screws for fastening at ends of frame members.
Patent AT-E305863-T1 (AT)
Inventor: SPIER WILLI
IPC: B60P1/00
Filed: 1997-07-11
Granted: 2005-10-15
Abstract: The intermediate floor has two rows (R1,R2) of several elements (BE) mounted to pivot upwards around a horizontal axis (1) on the structure side wall (2). They pivot adjacent to the respective row from a vertical not-in-use position lying on the side wall to a horizontal in-use position. In the horizontal in-use position the elements are supported on the floor (4) on one side by a corresponding folding support (3), and on the other side are positionally fixed in relation to each other.
Patent AT-E262731-T1 (AT)
Inventor: MADER LEOPOLD
IPC: H01H50/36
Filed: 1997-08-20
Granted: 2004-04-15
Abstract: A magnet system has a U-shaped core yoke whose yoke leg and core leg form a magnetic flux circuit together with an armature. A constriction section with reduced cross-section is provided at a location of the magnetic flux circuit, preferably at the core leg; a ferromagnetic bridge element with a flat permanent magnet is coupled to the magnetic flux circuit parallel thereto. Since the constriction section enters into saturation when the armature is attracted, the armature is held fast opposite a restoring spring. As a result of the inventive arrangement, a geometry for a magnetic circuit arrangement that is fast and inexpensive to manufacture is provided.
Patent AT-E225237-T1 (AT)
Inventor: SOREL ALAIN
IPC: B23D35/00
Filed: 1997-07-11
Granted: 2002-10-15
Abstract: The stamping machine has a lower matrix stamping section (86) which is fixed on a moving chassis. Up to 24 stamping sections can be placed on the body. There is an upper tool support (50) for a stamping tool (62). A fixed holder (60) supports the stamping tool. The upper section positions the tool with respect to the support section and commands vertical movement of the tool in the support.
Patent AT-E232515-T1 (AT)
Inventor: SATO ATSUSHI
IPC: C07D209/34
Filed: 1997-01-16
Granted: 2003-02-15
Abstract: The present invention is directed to an oxindole derivative represented by formula (1): <CHEM> (wherein R represents a methyl group or a methoxy group), and pharmaceuticals containing the compound. The compound exhibits excellent granulation inhibiting activity while providing minimal liver toxicity and is useful as a pharmaceutical in the prevention and treatment of articular rheumatism, arteriosclerosis, hepatocirrhosis, etc., and also in the prevention and treatment of arthrosis deformans, psoriasis, gout, nephritis, angiitis, inflammatory intestinal diseases (ulcerative colitis, Crohn's disease), bronchitis, and chronic granulomatosis, etc.
Patent AT-E423211-T1 (AT)
Inventor: DUCHARS MATTHEW GUY
IPC: C12N9/14
Filed: 1997-02-20
Granted: 2009-03-15
Abstract: PCT No. PCT/GB97/00465 Sec. 371 Date Aug. 21, 1998 Sec. 102(e) Date Aug. 21, 1998 PCT Filed Feb. 20, 1997 PCT Pub. No. WO97/31118 PCT Pub. Date Aug. 28, 1997Plasmids which comprise: (1) an origin of replication; (2) an additional sequence required for plasmid replication or preferably a gene giving a selective advantage; and (3) two expression cassettes each of which are located between (1) and (2) but are separated by (1) and (2) from each other; and which are free from inverted repeat sequences (other than in (3)) are highly persistent though successive generations of microbes containing them.
Patent AT-E182092-T1 (AT)
Inventor: WIETING ENNO
IPC: B21C51/00
Filed: 1997-02-07
Granted: 1999-07-15
Abstract: The invention relates to a process for marking of defective spots in hot workpieces to be tested during which, after receiving the marking command from a stationary device, a marking agent is applied to the surface of the workpiece using compressed air at least for the duration of the display signal. The marking agent starts flowing in an unimpeded and uninterrupted manner to the discharge area and meanwhile sufficient supply of pressurised air, satisfactory operation of all electrical connections including all electrical circuits, and the level of the marking ayant in the device are monitored. The invention also relates to a device for carrying out said process.
Patent AT-E277598-T1 (AT)
Inventor: AGGER NICOLAI
IPC: A61K9/00
Filed: 1997-07-16
Granted: 2004-10-15
Abstract: The invention relates to an orally administrable, paste-like composition for veterinary use, in particular for ruminants, and more particularly a composition comprising a calcium compound for controlling milk fever. A veterinarily active compound is suspended in a two-phase oily composition comprising a liquid, veterinarily acceptable oil component and a solid, veterinarily acceptable fat component, said fat component forming a coherent structure of crystals in said liquid oil component.
Patent AT-E251909-T1 (AT)
Inventor: SIREN MATTI
IPC: A61K/
Filed: 1997-06-23
Granted: 2003-11-15
Abstract: The invention relates to the use of a compound containing a high density, negatively charged domain of vicinally oriented radicals for the preparing of a medicament providing a growth factor modulating activity in mammals including man.
Patent AT-E191970-T1 (AT)
Inventor: NAUGHTON MARTIN LAWRENCE
IPC: F24D13/04
Filed: 1997-07-11
Granted: 2000-05-15
Abstract: A space heater is disclosed, comprising a housing, a heat source within the housing and a plurality of openings to allow the convection of air through the housing, in which:the heat source comprises a pair of panels defining between them a closed compartment, a liquid within and partially filling the compartment and an electrical heating element extending within the compartment, substantially parallel to the panels and in thermal contact with the liquid;the compartment is sub-divided into a lower liquid chamber and an upper expansion chamber and the cross-sectional area of the liquid chamber where it meets the expansion chamber is less than that of the expansion chamber; andthe openings in the housing allow radiant heat from the heat source to escape from the housing.In further embodiments, the lower liquid chamber contains liquid at room temperature, but the upper expansion chamber does not.